Spire Healthcare Group (SPI) Receives Underweight Rating from Barclays

Barclays restated their underweight rating on shares of Spire Healthcare Group (LON:SPI) in a report released on Friday morning, Digital Look reports. They currently have a GBX 115 ($1.50) target price on the stock.

A number of other brokerages have also weighed in on SPI. Peel Hunt restated a hold rating on shares of Spire Healthcare Group in a report on Friday, February 1st. Liberum Capital restated a hold rating on shares of Spire Healthcare Group in a report on Thursday, March 14th. JPMorgan Chase & Co. restated a neutral rating on shares of Spire Healthcare Group in a report on Wednesday, January 16th. Credit Suisse Group lowered their price objective on shares of Spire Healthcare Group from GBX 85 ($1.11) to GBX 75 ($0.98) and set an underperform rating for the company in a report on Wednesday, March 13th. Finally, Numis Securities restated a buy rating and issued a GBX 163 ($2.13) price objective on shares of Spire Healthcare Group in a report on Thursday, February 28th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average target price of GBX 128.75 ($1.68).

Shares of SPI opened at GBX 122.10 ($1.60) on Friday. The company has a market capitalization of $489.72 million and a PE ratio of 43.61. The company has a debt-to-equity ratio of 48.52, a current ratio of 1.44 and a quick ratio of 0.95. Spire Healthcare Group has a fifty-two week low of GBX 96.15 ($1.26) and a fifty-two week high of GBX 259.20 ($3.39).

The firm also recently disclosed a dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Thursday, May 30th will be issued a GBX 2.50 ($0.03) dividend. This represents a dividend yield of 1.95%. This is a positive change from Spire Healthcare Group’s previous dividend of $1.30. The ex-dividend date is Thursday, May 30th. Spire Healthcare Group’s payout ratio is presently 1.43%.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

Featured Story: How accurate is the Rule of 72?

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.